Hemp CBD Oil and the Endocannabinoid System
Dr. Gregory Gerdeman, Chief Scientific Officer, United Cannabis Corporation
The reemergence of hemp as an agricultural crop has been fueled by a revival in recognizing cannabis to be a legitimate botanical medicine. Considerable scientific research has been important for this resurgence, including two discoveries of major importance: 1) the human endocannabinoid system (ECS) and 2) the therapeutic promise of cannabidiol (CBD). Research into the ECS has elaborated a major natural regulator of human homeostasis and disease, with many promising implications for cannabinoids as therapeutics. Concurrently, CBD research has resulted in scientific and clinical evidence that this major component of cannabis resin has compelling therapeutic properties, separable from the hallmark psychoactive effects of THC. This talk will review some key findings and point to the importance of research to the industry of hemp- derived CBD.
Dr. Greg Gerdeman is a neuroscientist and pioneer in understanding the mammalian endocannabinoid system, including its roles in synaptic plasticity, neuroprotection, and the “runner’s high” evoked by aerobic exercise. He has studied and lectured on cannabinoid pharmacology for over two decades, both as an academic and a cannabis industry scientist. Currently serving as Chief Scientific Officer of United Cannabis (UCANN), Dr Gerdeman is also an Assistant Professor in the Dept of Pharmaceutical Sciences in the USF College of Pharmacy. He is a widely cited expert on the biological rationales for cannabis as a medicine.